Our previous research indicated that FAM134B is overexpressed in HCC tissues compared to adjacent non-tumor tissues and promotes HCC progression by activating the AKT signaling pathway [13], although the precise mechanism of this activation is yet to be fully elucidated. Here, RETREG1 is linked to hepatocellular carcinoma.